Trial
NCT03281694
The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine
Phase IWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
—
Condition
Cognitive Change
Intervention
Placebo
Why stopped
Drug supplier did not come through.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-11-06